Latest Whitepapers

This whitepaper highlights expert perspectives on tackling the toughest purification barriers in complex mAb development. It explores how targeted process design and innovative resin technologies can drive higher purity, yield and robustness.

This whitepaper explores common pitfalls in mAb development and how to overcome them with better planning, process standardization and technology choices.

This whitepaper explores how peptones have already improved yields and highlights strategies to fine-tune their application for even greater performance.

This whitepaper explores how peptones are revolutionizing biopharmaceutical manufacturing, offering a proven path to higher productivity and quality.

This whitepaper explores how AAV titration and anti-AAV antibody ELISA kits streamline AAV-based gene therapy research, enhancing patient stratification, optimizing preclinical studies and supporting regulatory compliance.

This whitepaper discusses the classification of bsAbs targeting immunomodulatory checkpoints and highlights their applications in cancer immunotherapy.

This article explores how mRNA and VLP vaccines represent a significant advancement in vaccine technology and will play a role in protection against infectious diseases.

This whitepaper explores the benefits of an automated platform compared to that of traditional Western blotting workflow, highlighting real-life case studies and demonstrating the advantages of multiplexing.

This whitepaper explores innovative chromatography techniques to enhance aggregate removal and improve overall mAb recovery, ensuring higher quality and more effective therapeutic solutions.

Scientists are constantly innovating newer technologies that allow them to understand nuances within these drugs and find ways to manufacture them more reliably.